Winston Kung - 04 Jun 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
COO, CFO
Signature
/s/ Robert Ticktin, by power of attorney
Issuer symbol
PMVP
Transactions as of
04 Jun 2021
Transactions value $
$-137,385
Form type
4
Filing time
07 Jun 2021, 21:36:07 UTC
Previous filing
08 Jun 2021
Next filing
08 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $14,490 +4,500 +281% $3.22 6,100 04 Jun 2021 Direct
transaction PMVP Common Stock Sale $-151,875 -4,500 -73.8% $33.75* 1,600 04 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -4,500 -1.94% $0.000000 228,034 04 Jun 2021 Common Stock 4,500 $3.22 Direct F2
holding PMVP Stock Option (right to buy) 237,412 04 Jun 2021 Common Stock 237,412 $3.22 See footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
F2 The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant.
F3 All of the shares subject to the option are vested and immediately exercisable.
F4 The shares are held of record by the Winston Kung Irrevocable Family Trust for the benefit of the reporting person's immediate family.